Overview

Intrapleural Urokinase for Retained Hemothorax

Status:
Unknown status

Trial end date:
2013-08-01

Target enrollment:

Participant gender:

Summary

Intrapleural thrombolytic treatment with urokinase for retained hemothorax is effective and safe. However, previous study was limited in prospective observation study without control group.

Phase:

Phase 3

Details

Lead Sponsor:

National Taiwan University Hospital